Diseases of the Esophagus · 2006 · 51 citations · 26 references
MedicineOncologyPathologyMolecular OncologyNeoplasiaTumor ProgressionEsophageal CancerImmunohistochemistryMalignant NeoplasmsSquamous Cell CarcinomaTumor DifferentiationTumor MarkersClinicopathological CorrelationMembrane Type Matrix MetalloproteinasesSquamous Cell Carcinoma HistologySquamous Cell Carcinoma HistopathologySquamous Cell Carcinoma PathologyTumor Differentiation AssessmentTumor-associated Glycoproteins
Extracellular matrix metalloproteinase inducer (EMMPRIN) and the type II transmembrane serine protease, matriptase, are expressed in several human cancers and play an important role in tumor progression. The aim of the present study was to investigate the immuno-staining patterns of EMMPRIN and matriptase in patients with esophageal squamous cell carcinomas (SCC) and correlate the percentage tumor staining with tumor differentiation and clinical parameters. EMMPRIN and matriptase immunoreactivity was seen on the cell membrane and in the cytoplasm of tumor cells in all 41 cases of esophageal SCC evaluated. The percentage tumor staining of EMMPRIN was 48 +/- 3% for well differentiated, 73 +/- 3% for moderately differentiated, and 92 +/- 3% for poorly differentiated esophageal SCC. Higher percentage tumor staining with EMMPRIN correlated significantly with poorly differentiated esophageal SCC (P < 0.05). The percentage tumor staining with matriptase correlated significantly with tumor differentiation (52 +/- 3% for well differentiated, 85 +/- 2% for moderately differentiated, and 88 +/- 3% for poorly differentiated esophageal SCC). Additionally, higher percentage tumor staining with matriptase was significantly correlated with the advanced N and M stages (P < 0.05). Our results demonstrate that EMMPRIN and matriptase are over-expressed in esophageal SCC and are correlated with advanced clinicopathological stages. Pharmacological agents targeting EMMPRIN and matriptase expressions may be beneficial in the treatment of esophageal SCC.
26
Sarah Landis, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 1999 · 3.1K citations · Full text
Medicine, Biostatistics, Oncology +17
Toshihiko Takeuchi, Jennifer L. Harris, Wei Huang et al. · Journal of Biological Chemistry · 2000 · 437 citations · Full text